NCT05895591

Brief Summary

The aim of the study is to determine the efficacy of the investigational product "Cream " :

  • on skin network after 56 days of daily application
  • on biological parameters linked to cellular communication involved in senescence
  • on sebum composition (metagenomics and metabolomics analysis)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 12, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2021

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2021

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 19, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 8, 2023

Completed
Last Updated

June 8, 2023

Status Verified

April 1, 2023

Enrollment Period

2 months

First QC Date

May 19, 2023

Last Update Submit

May 31, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • Assessment of skin network (SRa parameter) by Fringe projection on silicone rubber replica (on one randomized forearm)

    SRa: Average roughness (mm). Average variations in amplitude of the relief integrated into the studied surface.

    Change from baseline to Day 57

  • Assessment of skin network (SRq parameter) by Fringe projection on silicone rubber replica (on one randomized forearm)

    SRq: Roughness with regards to the average quadratic plan (mm).

    Change from baseline to Day 57

  • Assessment of sebum metabolites' composition

    Metabolomics analysis from sebum samples using mass spectrometry

    Change from baseline to Day 57

  • Assessment of skin metagenomic composition

    Metagenomics analysis from sebum samples using targeted DNA sequencing

    Change from baseline to Day 57

  • Expression of cellular communication markers linked to senescence

    RNA expression from skin biopsies using RNA-Seq

    Day 57

Study Arms (1)

Treated Group

EXPERIMENTAL

all subjects will apply the study product

Other: Anti-aging cosmetic care product

Interventions

* frequency of application: Once a day (in the morning) * modalities of application: Apply the cream on face (according to normal conditions of use) and on treated forearm, massage until complete penetration * area: The whole face, neck, neckline and one randomized forearm (external photo-exposed area) the other forearm is untreated * duration of investigational product application: 56 days (a window of + 72 hours is allowed) * quantity: 2 pressures of product for the whole face, neck and neckline and 1 pressure of product for the treated forearm

Treated Group

Eligibility Criteria

Age35 Years - 55 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • sensitive skin (declaratory judgment)
  • face skin type: combination to normal skin
  • presenting wrinkles and/or finelines on the whole face
  • displaying saggy skin on the face (loss of firmness)
  • presenting a lack of skin radiance, dull complexion and an inhomogeneous skin on the face

You may not qualify if:

  • Related to the treatment/product:
  • having had any surgery, chemical or significant invasive dermo-treatment on the experimental area considered by the Investigator liable to interfere with the study data
  • having undergone techniques with aesthetic aim on study areas (chemical peel, mechanical dermabrasion, laser, pulsed flash lamp etc.) or having made injections of anti-wrinkle products (collagen, hyaluronic acid, botulinic toxin etc.)
  • having applied products with an anti-aging action (Retinoic acid, retinol, retinaldehyde, A.H.A. etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spincontrol

Tours, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2023

First Posted

June 8, 2023

Study Start

October 12, 2021

Primary Completion

December 7, 2021

Study Completion

December 14, 2021

Last Updated

June 8, 2023

Record last verified: 2023-04

Locations